New sleep pill HEC83518 passes first safety check in healthy volunteers
NCT ID NCT04596007
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tested a new insomnia drug called HEC83518 in 74 healthy Chinese adults aged 18 to 45. The main goal was to check safety and side effects after a single dose. Researchers also measured how the drug moves through the body. This is a first step to see if the drug is safe enough for future studies in people with insomnia.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INSOMNIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Shanghai xuhui district central hospital
Shanghai, Shanghai Municipality, China